MA
43
2
FLR
58
2
AMGN
33
3
PFG
53
8
DGX
46
3
ESS
42
6
SLB
42
-2
LB
69
59
MO
44
2
ADM
44
-9
TMO
44
-2
NEM
50
2
ICE
52
2
CNP
62
12
TXN
65
-3
AON
62
2
IRM
31
3
EXR
37
6
UHS
43
-4
EQT
54
4
MA
43
2
FLR
58
2
AMGN
33
3
PFG
53
8
DGX
46
3
ESS
42
6
SLB
42
-2
LB
69
59
MO
44
2
ADM
44
-9
TMO
44
-2
NEM
50
2
ICE
52
2
CNP
62
12
TXN
65
-3
AON
62
2
IRM
31
3
EXR
37
6
UHS
43
-4
EQT
54
4
Financhill
Back

Nektar Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49

NKTR
Nektar Therapeutics

Last Price:
$23.85
Seasonality Move:
2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Nektar Therapeutics Stock Forecast

  • Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 22.2% based on the past 31 years of stock performance.
  • Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
  • Is Nektar Therapeutics Stock Undervalued?
    The current Nektar Therapeutics [NKTR] share price is $24.14. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Nektar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 22.2% based on the past 31 years of stock performance.

Nektar Therapeutics Stock Rating

Sell
49
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics overpriced?

  • Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%

Nektar Therapeutics Stock Price History

Is NKTR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com

52-Week Data

52-Week High:
37.38
52-Week Low:
6.48

Prediction Charts

Market Cap:
299.5M
Price in USD:
24.14
Volume:
958.5K
Beta:
1.22

Technical Analysis

SMA50:
14.80
SMA100:
13.02
SMA200:
14.65
52-Wk Change:
9.48%

Stock Predictions

  • Is Nektar Therapeutics stock public?
    Yes, Nektar Therapeutics is a publicly traded company.
  • What is the Nektar Therapeutics stock quote today?
    The Nektar Therapeutics stock price is 24.14 USD today.
  • How to buy Nektar Therapeutics stock online?
    You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 31.15 29.68 33.81 27.10
Jun-27 29.21 25.76 29.26 25.30
Jun-30 27.08 25.84 27.99 25.03
Jul-1 24.96 24.59 25.74 24.19
Jul-2 24.07 25.53 26.59 24.07
Jul-3 25.29 24.76 26.43 23.81
Jul-7 24.00 23.47 24.33 22.09
Jul-8 23.81 22.73 23.98 21.87
Jul-9 23.25 23.36 23.97 22.61
Jul-10 24.09 25.10 25.57 22.67
Jul-11 24.82 25.01 26.29 23.86
Jul-14 24.61 24.41 25.15 23.66
Jul-15 24.52 23.80 24.73 23.06
Jul-16 24.01 24.14 24.64 23.06

Nektar Therapeutics Earnings

Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Nektar Therapeutics Forecast Revenue Growth

Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.